These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 30308427)
1. Efficacy of levetiracetam for reducing rolandic discharges in comparison with carbamazepine and valproate sodium in rolandic epilepsy. Kanemura H; Sano F; Ohyama T; Aihara M Seizure; 2018 Nov; 62():79-83. PubMed ID: 30308427 [TBL] [Abstract][Full Text] [Related]
2. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy. Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B; J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814 [TBL] [Abstract][Full Text] [Related]
3. Levetiracetam versus carbamazepine in treatment of rolandic epilepsy. Asadi-Pooya AA; Forouzesh M; Eidi H; Mirzaghafour SE Epilepsy Behav; 2019 May; 94():1-8. PubMed ID: 30884401 [TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study. Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of levetiracetam and valproic acid as low-dose monotherapies for children with typical benign childhood epilepsy with centrotemporal spikes (BECTS). Xiao F; An D; Deng H; Chen S; Ren J; Zhou D Seizure; 2014 Oct; 23(9):756-61. PubMed ID: 24998415 [TBL] [Abstract][Full Text] [Related]
7. Clinical features of benign epilepsy of childhood with centrotemporal spikes in chinese children. Liu MJ; Su XJ; Md XS; Wu GF; Zhang YQ; Gao L; Wang W; Liao JX; Wang H; Mai JN; Gao JY; Shu XM; Huang SP; Zhang L; Zou LP Medicine (Baltimore); 2017 Jan; 96(4):e5623. PubMed ID: 28121917 [TBL] [Abstract][Full Text] [Related]
8. Outcome analysis of children with rolandic discharges on EEG: A real-world study. Gu W; Chen J; Tian W; Tao W; Chen J; Zhang G; Zheng G; Wu C Seizure; 2020 Nov; 82():105-108. PubMed ID: 33059311 [TBL] [Abstract][Full Text] [Related]
9. Resting state signal latency assesses the propagation of intrinsic activations and estimates anti-epileptic effect of levetiracetam in Rolandic epilepsy. Xu Q; Hu Z; Yang F; Bernhardt BC; Zhang Q; Stufflebeaskm SM; Zhang Z; Lu G Brain Res Bull; 2020 Sep; 162():125-131. PubMed ID: 32535220 [TBL] [Abstract][Full Text] [Related]
10. Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs). Stepanova D; Beran RG Seizure; 2014 May; 23(5):371-6. PubMed ID: 24630809 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of anti-epileptic drugs-an internet study. Wieshmann UC; Baker G Acta Neurol Scand; 2017 May; 135(5):533-539. PubMed ID: 27757951 [TBL] [Abstract][Full Text] [Related]
12. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients. Tumay Y; Altun Y; Ekmekci K; Ozkul Y Clin Neuropharmacol; 2013; 36(2):55-8. PubMed ID: 23503548 [TBL] [Abstract][Full Text] [Related]
13. Behavioral problems in children of mothers with epilepsy prenatally exposed to valproate, carbamazepine, lamotrigine, or levetiracetam monotherapy. Huber-Mollema Y; Oort FJ; Lindhout D; Rodenburg R Epilepsia; 2019 Jun; 60(6):1069-1082. PubMed ID: 31166022 [TBL] [Abstract][Full Text] [Related]
14. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China. Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980 [TBL] [Abstract][Full Text] [Related]
15. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures. Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881 [TBL] [Abstract][Full Text] [Related]
16. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs. Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430 [TBL] [Abstract][Full Text] [Related]
17. Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis. Santhosh AP; Kumar Goyal M; Modi M; Kharbanda PS; Ahuja CK; Tandyala N; Prabhat N; Singh R; Mehta S; Vinay Mahesh K Acta Neurol Scand; 2021 Mar; 143(3):242-247. PubMed ID: 33006755 [TBL] [Abstract][Full Text] [Related]
18. [Efficacy of carbamazepine, valproate and topiramate in the treatment of medial temporal epilepsy in children]. Boldyreva SR; Ermakov AIu Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4):41-7. PubMed ID: 20517209 [TBL] [Abstract][Full Text] [Related]
19. Vitamin D deficiency in children with epilepsy taking valproate and levetiracetam as monotherapy. Durá-Travé T; Gallinas-Victoriano F; Malumbres-Chacón M; Moreno-Gónzalez P; Aguilera-Albesa S; Yoldi-Petri ME Epilepsy Res; 2018 Jan; 139():80-84. PubMed ID: 29197669 [TBL] [Abstract][Full Text] [Related]
20. Initiation of treatment and selection of antiepileptic drugs in childhood epilepsy. Oka E; Murakami N; Ogino T; Kobayashi K; Ohmori I; Akiyama T; Ito M Epilepsia; 2004; 45 Suppl 8():17-9. PubMed ID: 15610189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]